CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis
Dirk Westhölter, Fabian Schumacher, Nuria Wülfinghoff, Sivagurunathan Sutharsan, Svenja Straßburg, Burkhard Kleuser, Peter A. Horn, Sebastian Reuter, Erich Gulbins, Christian Taube, Matthias Welsner
Topics & Concepts
Cystic fibrosisMedicineSphingolipidInternal medicineCell biologyBiologySphingolipid Metabolism and SignalingCystic Fibrosis Research AdvancesMetabolomics and Mass Spectrometry Studies